🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We are excited to introduce the incoming UCLA Stein Eye Institute class of 2028 #ophthalmology residents! Welcome to UCLA!

Today we report in Nature Communications the development of laboratory-evolved CBE6 cytosine base editors that offer high on-target C•G-to-T•A editing, virtually no A•T-to-G•C editing, low off-target editing, broad sequence context compatibility, and compatibility with multiple Cas

I'm happy to announce that our book, "Future Of Technology In Medicine, The: From Cyborgs To Curing Paralysis", made it to BookAuthority's Best New Future of Technology Books: bookauthority.org/books/new-futu… It earned the #8 overall rank for 2024.

Today in @Science_Magazine we report the laboratory evolution of compact degrons that enable targeted protein degradation triggered by an otherwise-inert small molecule, a multidisciplinary study that integrates organic chemistry, molecular glues, protein evolution, genome

Swapping stethoscope for pipette to understand diabetic retinopathy - Emma Lessieur Contreras is a postdoctoral fellow at the University of California, Irvine under the supervision of Timothy Kern, focusing on the immune ... - ift.tt/Q6JS0CO

I am incredibly excited to announce the opening of the Ty Miller Lab at CWRU School of Medicine and University Hospitals in Cleveland! My lab will be dedicated to creating effective immunotherapies for brain tumor patients. Learn more at our freshly minted website - tymillerlab.org

Today we report in Nature Biomedical Engineering the eePASSIGE system, which uses evolved and engineered recombinases and prime editing to integrate large gene-sized DNA cargoes into the mammalian genome in an efficient, precise, and targeted manner. (1/13) drive.google.com/file/d/1WDMVqL…

We've developed a systems pharmacology-based strategy targeting GPCRs and evaluated its efficacy in multiple inherited retinal degeneration models. Proud to contribute to the study and congratulations to Henri Henri Leinonen! #ophthalmology #retina nature.com/articles/s4146…

Today we report in Nature Biotechnology a system for the laboratory evolution of engineered virus-like particles (eVLPs) that enables the discovery of eVLP variants with desired properties, including improved production and delivery potency. 1/13 PDF: drive.google.com/file/d/1E6Nr86…

We are beyond excited to welcome the UCLA #Ophthalmology Residency Class of 2029! Congratulations to this incredible group of future eye surgeons—we can’t wait to have you join us!! #MatchDay